Co-Authors
This is a "connection" page, showing publications co-authored by Anwar Hashem and Mohamed Alfaleh.
Connection Strength
1.610
-
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1. Vaccines (Basel). 2021 Aug 04; 9(8).
Score: 0.240
-
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia. Viruses. 2021 07 20; 13(7).
Score: 0.239
-
Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies. Pathogens. 2020 Dec 19; 9(12).
Score: 0.230
-
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients. Viruses. 2020 12 04; 12(12).
Score: 0.229
-
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients. Sci Rep. 2020 10 06; 10(1):16561.
Score: 0.227
-
Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay. Front Microbiol. 2020; 11:2020.
Score: 0.225
-
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review. Travel Med Infect Dis. 2020 May - Jun; 35:101735.
Score: 0.220